Literature DB >> 16433807

Synergistic antimicrobial activity by combining an allylamine with benzoyl peroxide with expanded coverage against yeast and bacterial species.

C G Burkhart1, C N Burkhart, N Isham.   

Abstract

BACKGROUND: Dermatophyte infections can be polymicrobial. Topical antifungal therapies offer limited coverage of yeasts and Gram-positive and Gram-negative bacteria. Moreover, the increased usage of these topical antimicrobial agents has resulted in the development of resistant cases. Benzoyl peroxide (BP), used in concert with antimicrobial agents containing an accessible tertiary amine, has previously been shown to increase radical activity and biological effect.
OBJECTIVES: To determine the applicability of using the tertiary amine terbinafine in concert with BP in dermatophyte and mixed skin infections by means of in vitro testing.
METHODS: In this preliminary in vitro study, the effect of BP, alone and in combination with terbinafine, was tested against Candida albicans, Pseudomonas aeruginosa and Staphylococcus aureus isolates following a checkerboard modification of the National Committee for Clinical Laboratory Standards M27-A2 and M7-A6. The individual minimum inhibitory concentrations of terbinafine, BP, and the combination, were determined against each isolate.
RESULTS: The combination of BP with terbinafine led to additive activities against the majority of Candida albicans isolates tested and additionally expanded the bacterial coverage of terbinafine.
CONCLUSIONS: The combination of antifungal agents bearing a tertiary amine with BP may have benefit in polymicrobial infections, given its wider antimicrobial coverage. Further appreciation of this mechanism of catalysis of BP radical formation by certain antimicrobials and other tertiary amine-containing compounds may lead to the discovery of improved treatments for several dermatological conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16433807     DOI: 10.1111/j.1365-2133.2005.06924.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Co-operative inhibitory effects of hydrogen peroxide and iodine against bacterial and yeast species.

Authors:  Elena I Zubko; Mikhajlo K Zubko
Journal:  BMC Res Notes       Date:  2013-07-15

2.  Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis.

Authors:  Cedric Charrier; Catherine Rodger; Jennifer Robertson; Aleksandra Kowalczuk; Nicola Shand; Douglas Fraser-Pitt; Derry Mercer; Deborah O'Neil
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

Review 3.  Peroxides with Anthelmintic, Antiprotozoal, Fungicidal and Antiviral Bioactivity: Properties, Synthesis and Reactions.

Authors:  Vera A Vil'; Ivan A Yaremenko; Alexey I Ilovaisky; Alexander O Terent'ev
Journal:  Molecules       Date:  2017-11-02       Impact factor: 4.411

4.  Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex.

Authors:  Douglas Fraser-Pitt; Derry Mercer; Emma Lovie; Jennifer Robertson; Deborah O'Neil
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection.

Authors:  Douglas J Fraser-Pitt; Derry K Mercer; Daniel Smith; Aleksandra Kowalczuk; Jennifer Robertson; Emma Lovie; Peter Perenyi; Michelle Cole; Michel Doumith; Robert L R Hill; Katie L Hopkins; Neil Woodford; Deborah A O'Neil
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.